Biliary Stents industry is anticipated to register 5.5% CAGR between 2023 and 2032 due to increasing prevalence of bile duct & chronic liver disease.
Selbyville, Delaware, Jan. 25, 2023 (GLOBE NEWSWIRE) —
The biliary stents market value is anticipated to surpass USD 699 million by 2032, as per a new research report announced by Global Market Insights Inc.
Number of people being diagnosed with gallstones and other biliary disorders is increasing steadily, contributing to the rise in demand for minimally invasive surgical procedures. The awareness about the diagnosis and treatment of a wide range of gastrointestinal diseases is also growing at a considerable rate. Advanced technologies are thus being unveiled to improve patient outcomes and boost efficiency while carrying out stenting procedures.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4034
Minimal risks post placement to improve usage of metal stents
Biliary stents market revenue from the metal stent segment was valued at more than USD 253 million in 2022. These stents are thin-wired, mesh-like tubes that come in several lengths and diameters. Metal stents offer better patency, minimal slippage post-placement, and have a longer lifespan. Self-expandable stents have a post expansion diameter ranging from 6 to 10 mm. The high occurrence of diseases affecting the bile duct, such as biliary leaks, pancreatic cancer, and gallstones will bolster the usage of metal stents.
Browse key industry insights spread across 139 pages with 171 market data tables & 10 figures & charts from the report, “Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
Biliary stents to emerge as preferred gallstones treatment solution
Gallstones segment held over 52% growth rate of biliary stents market in 2022. This is attributed to unhealthy lifestyle changes, such as the adoption of sedentary lifestyles and a family history of gallstones. Although termed as non-fatal, gallstones can create blockages in the biliary tract, which is why it is essential to manage them effectively. Patients are also becoming aware of the availability of innovative treatments for biliary system diseases, thereby spurring the usage of biliary stents as a solution for gallstones.
Integration of advanced healthcare infrastructure will increase patients’ preference for biliary disease treatment in hospitals
Hospital segment development is credited to the growing prevalence of biliary disorders and a rising number of patients opting for stenting procedures. Technologically advanced healthcare infrastructure is also being developed. These factors, alongside the widespread availability of skilled medical professionals, can improve the overall quality of consulting, diagnosis, treatment, and care provided by hospitals, thereby contributing to biliary stent industry expansion.
Rising elderly population to drives biliary stent progression in North America
North America biliary stents market is witnessing a notable increase in the percentage of its elderly population, which is at high risk of contracting a variety of chronic ailments. These diseases include gallstones, pancreatic cancer, and other harmful obstructions. The growing prevalence of such conditions is likely to amplify progress for effective biliary treatments, including stents, and in turn, strengthen the regional market trends.
Secure a copy of the premium research report @ https://www.gminsights.com/securecheckout/paymenta/4034?gmpaycod=sugmp
Product launch initiatives from key players to define biliary stents market landscape
Some of the major participants in the biliary stents industry include Boston Scientific, B Braun Melsungen, Olympus Corporation, M.I Tech, CONMED Corporation, C.R. Bard (Becton, Dickinson & Company), ENDO-FLEX GmbH, Medtronic plc, and Cardinal Health, among many others.
Browse Our Reports Store – GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: email@example.com Read More News @ https://ibmag.com/
- Wellspring Acquires IP Pragmatics for End-to-End Tech Transfer and IP Management Solutions - February 2, 2023
- Structure Therapeutics Announces Pricing of Upsized Initial Public Offering - February 2, 2023
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Evolv Technologies Holdings (EVLV) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations - February 2, 2023